DRG uses cookies to improve your experience on this website. Some of the cookies we use are essential for parts of the website to operate. Please be aware that if you continue without changing your cookie settings, you consent to this. For more information on our use of cookies, please review our cookie policy.

Product and Market Planning

For nearly three decades, DRGC has been the strategic thought partner for the biopharmaceutical and medtech industry's new product planning and business development teams helping to address key product and market planning questions with actionable insights. In addition to our focus on close collaboration and open communication with our clients, our success is driven by a deep understanding of the nuances of relevant markets, products, and therapeutic areas, which inform realistic, targeted and data-driven recommendations.

Through a broad range of research techniques (e.g., primary and secondary research, qualitative and quantitative methods), we partner with our clients to assess the commercial potential of candidates in development and provide strategic and tactical insights and recommendations for in-licensing, development and commercial strategy, and product positioning and segment targeting.

Our success is driven by a deep understanding of the nuances of relevant markets, products and therapeutic areas

 

Holistic approach

We determine the attractiveness of relevant markets with the goal of identifying critical success factors for maximizing return on investment and potential for commercial success. Our holistic approach considers a range of factors such as the competitive environment and commercial potential in each indication or market at launch, development timelines/launch timing, pricing/sales potential, market access, development risk, and overall product lifecycle opportunities.

Custom Epidemiology

In addition to these core offerings, DRGC is able to leverage DRG's internal epidemiology team to develop custom epidemiology when required to address our clients' unique questions. Our syndicated epidemiology analyses have long served as the backbone of DRG's trusted market forecasts. Whether client questions focus on small and/or emerging markets, difficult-to-study diseases, or niche subpopulations, our custom epidemiology enables clients to develop strategy rooted in best-in-class analysis and proven epidemiological techniques.

 

Capabilities include:

  • Competitive landscape analysis
  • Commercial & market access landscaping
  • Emerging market assessment
  • Patient journey & flow analysis
  • Epidemiology & population segmentation
  • Product & market opportunity assessments and forecasting
  • Product positioning & strategy
  • Product value proposition development
  • Indication prioritization
  • Scenario planning